Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method
| Treament | Trials | |||||
|---|---|---|---|---|---|---|
| clinical deterioration | clinical improvement | deaths | viral clearance | |||
| progesterone | - | 1.31 [1.00; 1.71], 1 RCT, I2=0% unassessable degree of certainty | - | - | ||
| 5-alpha-reductase inhibitors | 0 | - | - | - | - | |
| dutasteride | 0 | - | - | - | - | |
| proxalutamide | 0 | - | - | - | - | |